About Cilicant Private Limited
Data last updated: 06 March 2026
Cilicant Private Limited is a private limited company based in Haveli, Maharashtra, India. It specialises in pharmaceutical packaging solutions, a part of the broader packaging sector. Incorporated on 03 March 2011, the company has been in operation for over 15 years.
Registered with ROC Pune under CIN U24100PN2011PTC138759.
Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹73.92 Lakh. Formerly known as Cilicant Chem Private Limited. It is led by directors including Rishika Manish Jain and Shiraz Bugwadia Homi.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Haveli, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹129.02 Cr, a growth of 36% compared to the previous year.
The company has a workforce of approximately 330 employees as per the latest available data.
The company is associated with 3 brands - Container Desiccant, Freshcant, Cilicant. As per MCA filings, the company has open charges of ₹163.67 Cr and satisfied charges of ₹26.3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cilicant.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressPlot No. 17 Ashra Estate Ubale Nagar Road, Wagholi Pune – 412207, Haveli, Maharashtra, India – 412207
-
IndustryPackaging, Pharmaceutical Packaging Solutions
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Cilicant Private Limited
Cilicant Private Limited operates multiple associated brands including Container Desiccant, Freshcant, and Cilicant. These brands represent Cilicant Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers moisture-absorbing products for homes and storage to prevent dampness and mold. | freshcant.com | |
| Drugs for the biopharma sector are manufactured and supplied. | cilicant.com | |
| Manufactures and supplies desiccants for moisture absorption in shipping containers. | containerdesiccant.com |
Competitors & Alternatives of Cilicant Private Limited
Brands and companies operating in the same space as Cilicant Private Limited include Legacy Pharma Solutions, Natural Capsules, SCHOTT Poonawalla and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Legacy Pharma Solutions
|
Contract pharmaceutical packaging company | Earth City, United States, United States | 2003 |
Natural Capsules
|
Manufacturing and supply chain services for biopharma sector are provided. | Bengaluru, India, India | 1993 |
SCHOTT Poonawalla
|
Packaging solutions for pharmaceutical and biotech industries are provided. | Mumbai, India, India | 1990 |
Ideal Cures
|
Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms | Mumbai, India, India | 1999 |
Sanner
|
Plastic packaging solutions for pharmaceutical products are manufactured. | Bensheim, Germany, Germany | 1894 |
Nutra-Med Packaging
|
Provider of drugs packaging services | Hanover, United States, United States | 1999 |
Eulysis
|
Diabetes management and lifestyle modification services are provided. | Cambridge, United States, United States | 2010 |
Bogorchid
|
Pest control products are manufactured by Bogorchid in India. | Chennai, India, India | 2016 |
AINIA
|
Pharmaceutical packaging services are provided by AINIA in Spain. | Paterna, Spain, Spain | 1987 |
BluSpider
|
Internet first brand offering smart device for pest control | Chennai, India, India | 2016 |
Business Activity of Cilicant Private Limited
Cilicant Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Cilicant Private Limited
Cilicant Private Limited is audited by S R B C & CO LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S R B C & CO LLP | blur-value | blur-value | blur-value |
Board of Directors of Cilicant Private Limited
Cilicant Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishika Manish Jain | Whole-Time Director | 03 Mar 2011 | 15 Years 4 Months | Current |
|
Shiraz Bugwadia Homi
Also directs:
Dui Investment Advisors Llp, Teen Investment Advisors Llp, Aek Management Consulting Llp and 5 more
|
Director | 22 Feb 2021 | 5 Years 4 Months | Current |
|
Manish Jain
Also directs:
Teen Labs Private Limited
|
Managing Director | 03 Mar 2011 | 15 Years 4 Months | Current |
Financials of Cilicant Private Limited FY 2025 filings available
Cilicant Private Limited reported revenue of ₹129.02 Cr (up 36% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Cilicant Private Limited
As of FY 2023, Cilicant Private Limited's shareholding pattern shows 80.82% by promoters, 19.18% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Cilicant Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2025 | Citi Bank N.A. | ₹10 Cr | Open |
| 31 Jul 2025 | Others | ₹2.5 Cr | Open |
| 27 May 2025 | Citi Bank N.A. | ₹10 Cr | Open |
| 27 Mar 2025 | Citi Bank N.A. | ₹35 Cr | Open |
| 18 Dec 2024 | Others | ₹27.5 Cr | Open |
Total charge records: 34 View all charges
Employees and EPFO Compliance at Cilicant Private Limited
Cilicant Private Limited has a workforce of 330 employees as of Sep 26, 2024.
Employee Count & EPFO Data of Cilicant Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Cilicant Private Limited
GSTIN & GST Filing Data of Cilicant Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Cilicant Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Cilicant Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Cilicant Private Limited
MSME Payment Delays by Cilicant Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Cilicant Private Limited
Subsidiaries & Group Companies of Cilicant Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Cilicant Private Limited with ownership details.
MCA Filings & Documents of Cilicant Private Limited
MCA Filings & Documents of Cilicant Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Cilicant Private Limited
Frequently Asked Questions about Cilicant Private Limited
Cilicant Private Limited is an active private limited company in the packaging sector based in Haveli, Maharashtra, India. It was incorporated on 03 March 2011 (15+ years old) and is registered under CIN U24100PN2011PTC138759. The company has 330 employees.
Cilicant Private Limited reported revenue of ₹129.02 Cr for FY 2024 (up 36.00% YoY).
The current directors of Cilicant Private Limited are:
The primary industry of Cilicant Private Limited is packaging. The company specifically operates in pharmaceutical packaging solutions. The company is currently active in this sector.
Cilicant Private Limited can be reached at the registered office: Plot No. 17 Ashra Estate Ubale Nagar Road, Wagholi Pune – 412207, Haveli, Maharashtra, India – 412207, or through the website cilicant.com.
The authorised capital is ₹1 Cr, and the paid-up capital is ₹73.92 Lakh.